Navigation Links
Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quarter Of 2013 Fiscal Year
Date:2/15/2013

JERSEY CITY, N.J., Feb. 15, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc.  (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced its financial and operational results for the three and six month periods ended December 31, 2012.  Complete financial results can be found in the Quarterly Report on Form 10-Q filed by Aoxing Pharma on February 14, 2013.

Financial Results:

Revenues for the three and six months ended December 31, 2012 were $3,314,768 and $5,919,531, respectively, representing a 56% and a 62% increase over the revenues realized in the comparable periods of fiscal year 2012.  In both periods the increase in revenues led to a 60% increase in gross profit.  The increase in revenue was mainly attributable to the increase in sales of our main product, Zhongtongan, which is now being marketed for gynecological and orthopaedic applications in addition to its core pediatric and stomotological market.  Sales of Zhongtongan accounted for 93% of sales during the quarter ended December 31, 2012. 

Aoxing Pharma completed a $10.2 million financing at the end of September 2012, which allowed it to make some crucial investments in the future of its business.  Operating expenses, therefore, were swelled during the second quarter of fiscal 2013 by two categories of targeted investment:

  • Research and development ("R&D") expenses were $1,090,104 during the three months ended December 31, 2012 and $1,219,659 during the six month period then ended, in both cases representing a several fold increase over R&D expense in fiscal 2012. 
  • Selling expenses in the amount of $1,706,202 incurred during the three months ended December 31, 2012 and $2,314
    '/>"/>

SOURCE Aoxing Pharmaceutical Company, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Aoxing Pharmaceutical Company Announces Management Change
2. Aoxing Pharmaceutical Company, Inc. Declines To Comment On Market Activity
3. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For First Quarter Of 2013 Fiscal Year
4. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Calif. , May 6, 2015  Genomic Health, ... Kim Popovits , Chairman of the Board, Chief Executive ... America Merrill Lynch 2015 Healthcare Conference in ... 3:40 p.m. Pacific Time (PT). To access ... go to the  Investor Relations  section of the company,s ...
(Date:5/6/2015)... 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... today that it will host a conference call and ... for the period ended March 31, 2015 and to ... its clinical program for aramchol. Conference ...
(Date:5/6/2015)... May 6, 2015 Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... Jonathan Lloyd Jones to the position of Chief ... Mr. Lloyd Jones brings to the ... business development experience.   Most recently, Mr. Lloyd Jones ...
Breaking Medicine Technology:Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
... Novel Biomarkers Displaying 90% Sensitivity in Breast ... ... announced today the,discovery and validation of the most frequent DNA alterations detected ... appeared in PLoS ONE. The study entitled, "Identification of,Novel High-Frequency DNA Methylation ...
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based ... has retained Financial,Relations Board (FRB), as its Investor ... HIV-1/AIDS vaccine human trial results need to be,conveyed ... AIDS,pandemic," stated Kathy Waller, co-president of FRB., ...
Cached Medicine Technology:Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 3GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 Established by ... wellness for the estimated 46 million Americans who suffer ... upon monthly medications to alleviate their symptoms. Medicationdiscountcard.com is ... to save patients money on the costs of these ... are used to treat the pain and inflammation in ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The American ... nomination period for its prestigious Integrated Water Resources Management ... IWRM approach to water resources projects. , An IWRM approach ... our establishment in 1964. In 2014, 12 projects were nominated ... IMPACT magazine features not only the 2014 AWRA IWRM Award ...
(Date:5/6/2015)... Wethersfield, Conn. (PRWEB) May 06, 2015 ... company in Wethersfield, Conn., has hired healthcare executive ... vice president. Olson will lead Qualidigm’s growing ... further Qualidigm’s mission to improve the quality, safety, ... Olson comes to Qualidigm from Interim HealthCare of ...
(Date:5/6/2015)... 2015 Novodiax announced today that ... of Innovations with Ed Begley Jr., airing via ... times TBA. , This segment will explore Novodiax, ... diagnostics. Audiences will learn about Novodiax’s polymer detection ... behind the scenes to investigate how, based on ...
(Date:5/6/2015)... The Center for Innovative Technology (CIT) announced ... e-Kare, Inc. of Fairfax, VA, a digital health company ... wounds. , Chronic wounds include pressure, venous, and diabetic ... over 6.5 million U.S. patients, costing over $25 billion. ... the Children’s National Medical Center (CNMC), e-Kare ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3
... Clearly Contacts, the ... BC Business Magazines, Top 100 Public Companies list for the fifth consecutive year. Clearly ... with revenue of $119 million for fiscal 2008. , ... Vancouver, British Columbia (Vocus) June 30, 2009 -- Clearly Contacts ...
... ... editor-in-chief of Orthopaedic Knowledge Online, William A. Grana, MD, MPH, will be inducted into ... July 11th during its Annual Meeting in Keystone, Colorado. , ... Keystone, CO (Vocus) June 30, 2009 ...
... Limited (Chiltern), a global clinical research organization (CRO) announced that ... , , Dr. Attila Lorinczi will lead ... Medical Society and the Society of Hungarian Urologists. Dr. Lorinczi ... years, most recently as a clinical operations manager. , ...
... Oxford University Press is proud to present the ... AMA Manual of Style, the "bible" ... involved in medical or scientific publishing. Because scientific, medical, and ... a new treatment hinges on how well the evidence to ...
... , MINNEAPOLIS, June 29 HealthFitness Corporation (NYSE ... employee health and productivity management solutions, announced today that the ... the close of market on June 26, 2009, when Russell ... indexes. , , About HealthFitness , ...
... in doctor,s office, for example, at risk, study shows , ... blood pressure that can happen in a doctor,s office, or ... sustained high blood pressure, a new study finds. , Researchers ... In white-coat hypertension, a patient,s blood pressure is high while ...
Cached Medicine News:Health News:Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 3Health News:Chiltern Opens Office in Budapest, Hungary 2Health News:AMA Manual of Style, the 'Bible' for Medical and Scientific Publishing, Gains Online Presence 2Health News:HealthFitness Added to the Russell Microcap Index 2Health News:Sporadic Spikes in Blood Pressure Hike Chances of Hypertension 2
Flexilog custom medical carts are configured to suite the requirements of FLEXILOG motility system users. With locking wheels and storage drawers, our carts are suitable for any care provider in any ...
Bravo Vacuum Pump. Complete with tubing....
Bravo Calibration Tubes...
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
Medicine Products: